NANOBIOTIX (EPA:NANO) NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
Transparency directive : regulatory news
28/05/2024 22:15
source : webdisclosure.com
NANOBIOTIX's latest news
17/12/2024 22:15
11/12/2024 22:15
09/12/2024 22:15
31/10/2024 08:30
11/10/2024 22:15
18/09/2024 22:15
04/09/2024 22:15
03/09/2024 22:15
08/08/2024 22:15
09/07/2024 22:15
Other stories
15/01/2025 04:34
15/01/2025 08:04
15/01/2025 07:05
15/01/2025 09:33
15/01/2025 03:08
14/01/2025 22:05
15/01/2025 11:27
15/01/2025 10:17
14/01/2025 19:51
15/01/2025 07:07
15/01/2025 10:17
15/01/2025 07:31
14/01/2025 21:01
14/01/2025 18:46
15/01/2025 11:07
15/01/2025 10:38
15/01/2025 01:16
15/01/2025 08:25
14/01/2025 13:13
14/01/2025 17:30
13/01/2025 23:45
14/01/2025 20:12
15/01/2025 05:40
14/01/2025 18:48
15/01/2025 07:00
14/01/2025 09:13
15/01/2025 08:07
15/01/2025 08:45
15/01/2025 08:59
15/01/2025 11:06
15/01/2025 08:59
14/01/2025 16:57
14/01/2025 10:24
14/01/2025 08:36
15/01/2025 00:32
15/01/2025 06:01
14/01/2025 18:23
13/01/2025 15:59